Men's Sexual Health  ·  Research

Millions of men are now on semaglutide — sold as Ozempic for diabetes, Wegovy for weight loss. The drug works. The weight comes off. Blood pressure drops. Cardiovascular risk falls. But buried in the package insert, listed among the side effects, is sexual dysfunction. Most men never read that line. Most doctors don't bring it up.

The research on what GLP-1 drugs actually do to men's sexual health has started to catch up — and the picture is more complicated one for most men.

A 2024 study published in the International Journal of Impotence Research, researchers used the TriNetX database — electronic health records from over 118 million individuals across 81 healthcare organizations — to identify non-diabetic, obese men (BMI > 30, ages 18–50) prescribed semaglutide for weight loss. Men with any prior ED diagnosis, testosterone deficiency, or pelvic surgery history were excluded. (IJIR, 2024)

"Our findings were in the opposite direction of the expectation, where we expected that weight loss would improve symptoms of erectile dysfunction." — Brian Liao, University of Texas Medical Branch (Urology Times)

A separate pharmacovigilance study using the FDA's Adverse Event Reporting System (FAERS), covering 2003–2024, identified 182 GLP-1-related sexual adverse events in men — not just ED, but reduced libido and orgasmic disorders. Semaglutide accounted for 21.4% of those reports. Most affected men were between 40 and 60 years old. (Biomolecules / PMC12467596, 2025)

The opposing argument is physiologically solid, and it starts with fat. Visceral adipose tissue — the fat stored around internal organs — is metabolically active. It elevates aromatase, an enzyme that converts testosterone into estradiol.
More visceral fat means lower free testosterone and higher estrogen. That hormonal shift suppresses libido and weakens erectile response.
Insulin resistance compounds the problem by impairing endothelial function and reducing nitric oxide availability, the molecule that triggers blood vessel dilation in the penis. (Adult & Pediatric Urology, 2026)

Semaglutide addresses this chain directly. Men who lose 10% or more of body weight on the drug have shown testosterone increases of 50–100+ ng/dL, driven by reduced aromatization from lower visceral fat.

A 2025 study presented at the Endocrine Society's annual meeting found that men on GLP-1 medications lost an average of 10% body weight over 18 months, with total testosterone rising by 18%. (Hone Health)

In men with type 2 diabetes — where ED prevalence runs between 35–75% — GLP-1 drugs have shown direct vascular benefits: lower blood pressure, reduced CRP, and improved endothelial function that measurably improves penile blood flow. (Fella Health, 2025)

A 2026 review in the International Journal of Impotence Research concluded that for men with significant metabolic disease, the cardiometabolic improvements from GLP-1 therapy likely outweigh the sexual side effect risk. (Nature/IJIR, 2026)

The two sides of this debate aren't contradicting each other — they're describing different men.

Who improves: Men with type 2 diabetes or significant obesity-driven metabolic dysfunction. Their ED is largely vascular and hormonal in origin. When semaglutide reduces visceral fat and reverses insulin resistance, the upstream drivers of their ED improve.

Who may worsen: Non-diabetic, obese men prescribed semaglutide purely for weight loss — the fastest-growing segment of GLP-1 users. In this group, the vascular damage underlying ED is less severe, and the drug's other potential effects — including possible autonomic dysregulation, hormonal shifts, and the physiological stress of rapid weight loss on lean mass — may tip the balance toward dysfunction rather than recovery.

There is also the underexplored issue of muscle and lean mass loss. Semaglutide-driven weight loss is not purely fat loss. Without resistance training, a meaningful portion of weight lost is lean mass.
Lower muscle mass is independently associated with lower testosterone. A 2024 Copenhagen trial showed men on semaglutide who added structured resistance training lost significantly less lean mass compared to standard care (1.8 lbs vs. 4.9 lbs over 26 weeks). (FormBlends, 2026)

Semaglutide is not inherently good or bad for men's sexual health. It depends on your metabolic starting point, how you train while on it, and whether anyone is paying attention to your hormone levels during treatment. The problem is that most prescriptions are handed out without any of that context, so it’s great you’re doing your own research.

The men most likely to see sexual improvement are the ones who were most metabolically compromised to begin with. The men most likely to be surprised by new ED are those who were healthy enough not to need it for metabolic reasons in the first place.

That gap between expectation and reality is exactly the kind of thing the healthcare system consistently fails to communicate — and exactly the kind of thing men over 30 need to know before they start.

Sources
TriNetX/IJIR Study (2024)  ·  FAERS Analysis / Biomolecules (2025)  ·  IJIR Perspective (2026)  ·  Urology Times  ·  Adult & Pediatric Urology (2026)  ·  Hone Health  ·  Fella Health (2025)  ·  FormBlends (2026)

Disclaimer

Everything published on Male Motive is built from credible, evidence-based sources and reviewed regularly to keep pace with current research and clinical thinking. That said, our articles are meant for general information and education — nothing more.

What you read here isn't a replacement for professional medical care. For anything involving your health — a symptom, a condition, a treatment you're weighing, or a new supplement or routine you're considering — talk to a licensed healthcare provider first. Don't put off seeing one, or brush off advice you've already been given, because of something you came across on this site.

We do our best to get things right, but Male Motive and its writers can't guarantee that every piece of information is complete, accurate, or applicable to your situation. Acting on what you read is your call, and your responsibility.

If something feels like an emergency, treat it like one — call your local emergency line or get to the nearest ER.